300 related articles for article (PubMed ID: 2410516)
41. Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.
Fleischmann J; Catalona WJ; Fair WR; Heston WD; Menon M
J Urol; 1983 Feb; 129(2):312-4. PubMed ID: 6187945
[TBL] [Abstract][Full Text] [Related]
42. Combined serum and bone marrow radioimmunoassays for prostatic acid phosphatase.
Cooper JF; Foti A; Herschman H
J Urol; 1979 Oct; 122(4):498-502. PubMed ID: 480493
[TBL] [Abstract][Full Text] [Related]
43. Human prostatic acid phosphatases: II. A double--antibody radioimmunoassay.
Choe BK; Pontes EJ; Morrison MK; Rose NR
Arch Androl; 1978 May; 1(3):227-33. PubMed ID: 83815
[TBL] [Abstract][Full Text] [Related]
44. A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
Goldenberg SL; Silver HK; Sullivan LD; Morse MJ; Archibald EL
Cancer; 1982 Nov; 50(9):1847-51. PubMed ID: 7116309
[TBL] [Abstract][Full Text] [Related]
45. [Are serum acid phosphatase levels of diagnostic significance in prostatic cancer? (author's transl)].
Bollack C; Helwig JJ; Offner M
Sem Hop; 1979 Dec 18-25; 55(43-44):2022-6. PubMed ID: 233445
[TBL] [Abstract][Full Text] [Related]
46. The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate.
Bruce AW; Mahan DE
Ann N Y Acad Sci; 1982; 390():110-21. PubMed ID: 6953923
[No Abstract] [Full Text] [Related]
47. [Bone scintigraphy, plasma ALP, TAP and PAP in patients with prostatic cancer].
Imamura A; Hoshi H; Jinnouchi S; Samejima M; Watanabe K
Kaku Igaku; 1988 Feb; 25(2):177-81. PubMed ID: 3386031
[No Abstract] [Full Text] [Related]
48. Acid phosphatase reappraised.
Gittes R
N Engl J Med; 1977 Dec; 297(25):1398-9. PubMed ID: 927455
[No Abstract] [Full Text] [Related]
49. Comparison of radioimmunoassay and immunoradiometric assay for serum prostatic acid phosphatase.
Sturgeon CM; Hussey AJ; Beynon L; Ritchie A; Chisholm GD; Micklem L; James K; Seth J
Clin Chim Acta; 1986 Nov; 161(1):47-57. PubMed ID: 2434268
[TBL] [Abstract][Full Text] [Related]
50. Current experience with radioimmunoassay techniques for prostatic acid phosphatase.
Cooper JF; Finkle WD
Prostate; 1980; 1(4):441-50. PubMed ID: 7279809
[TBL] [Abstract][Full Text] [Related]
51. [Radioimmunoassay kit for human prostate acid phosphatase--experimental and clinical evaluation of RIA-Quant P.A.P. Test Kit].
Wakabayashi K; Sugiyama Y; Takahashi E; Shida K
Kaku Igaku; 1982 Apr; 19(3):467-75. PubMed ID: 6182321
[No Abstract] [Full Text] [Related]
52. Prostatic acid phosphatase and prostatic cancer.
Foti AG; Cooper JF; Herschman H
Recent Results Cancer Res; 1979; 67():45-9. PubMed ID: 88065
[No Abstract] [Full Text] [Related]
53. [Evaluation of a double antibody radioimmunoassay kit for prostatic acid phosphatase (PAP) (author's transl)].
Yoshii M; Kousaka T; Morita R; Torizuka K; Kawamura J
Kaku Igaku; 1981 Dec; 18(10):1473-83. PubMed ID: 6176744
[No Abstract] [Full Text] [Related]
54. Immunochemical measurement of serum prostatic acid phosphatase (PAP). Clinical evaluation of radioimmunoassay and counter immunoelectrophoresis.
Gupta MK; Rajaraman S; Gupta SK; Hewitt CB; Deodhar SD
Am J Clin Pathol; 1981 Oct; 76(4):430-6. PubMed ID: 6170220
[TBL] [Abstract][Full Text] [Related]
55. Clinical utility of serum prostatic acid phosphatase measurements for detection (screening), diagnosis, and therapeutic monitoring of prostatic carcinoma; assessment of monoclonal and polyclonal enzymes and radioimmunoassays.
Kaplan LA; Chen IW; Sperling M; Bracken B; Stein EA
Am J Clin Pathol; 1985 Sep; 84(3):334-9. PubMed ID: 4036863
[TBL] [Abstract][Full Text] [Related]
56. Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease.
Griffiths J; Rippe DF; Panfili PR
Clin Chem; 1982 Jan; 28(1):183-6. PubMed ID: 7055908
[TBL] [Abstract][Full Text] [Related]
57. Human prostatic acid phosphatases: III. Counterimmunoelectrophoresis for rapid identification.
McDonald I; Rose NR; Pontes EJ; Choe BK
Arch Androl; 1978 May; 1(3):235-9. PubMed ID: 83816
[TBL] [Abstract][Full Text] [Related]
58. [Fundamental and clinical study of PAP 'Eiken' (author's transl)].
Higuchi Y; Kida T
Kaku Igaku; 1981 Dec; 18(10):1451-7. PubMed ID: 6176743
[No Abstract] [Full Text] [Related]
59. Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
Debruyne FM; van Munster PJ; van Groeninghen JC; Kirkels WJ
Urol Res; 1984; 12(5):233-7. PubMed ID: 6083652
[TBL] [Abstract][Full Text] [Related]
60. Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma.
Fossà SD; Skinningsrud A; Kaalhus O; Engeset A
Br J Urol; 1983 Jun; 55(3):306-11. PubMed ID: 6850249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
